Skip to main content
. 2017 Mar 7;114(12):3175–3180. doi: 10.1073/pnas.1618088114

Fig. S4.

Fig. S4.

(A) Comparison of cellular components of MV phosphopeptides that showed an increase in patients with cancer, with those of total phosphopeptides identified in MV. (B–D) Motif and the distribution of S/T/Y phosphopeptides that showed increase in patients with cancer in microvesicles.